SecBot SecBot
Insider Cluster (3 insiders) ·Filed Nov 13, 2026

UTHR

UNITED THERAPEUTICS Corp
BEARISH
Impact 4/10
Horizondays Processed3d 7h ago
Insider cluster: 3 insiders, $1.2M total
Actionable Insight ▼ Bearish

The CEO's large option exercise and concurrent sales under a 10b5-1 plan are routine for tax/estate planning, but the director's non-plan sale adds a modest bearish signal. Monitor for any further insider sales or changes to the $2.0B buyback authorization announced with earnings.

DirectionBearish
Confidencemedium
Horizondays

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt executed a large option exercise and sold a portion of the resulting shares, totaling approximately $6.6M in open-market sales over two days, alongside smaller sales by the EVP/General Counsel and a director. The CEO's sales were under a 10b5-1 plan, while the director's sale was not. The cluster follows Q3 earnings that beat revenue consensus but missed EPS estimates due to a $130M in-process R&D charge.

Key Financial Metrics

Direction
selling
Total Value
$7.6M
Insiders
3

Key Facts

  • CEO Martine Rothblatt exercised 28,500 derivative shares (9,500 each on Nov 11 and 12, plus 9,500 on Nov 12 at $0 strike) and sold 11,927 open-market shares on Nov 11-12 for ~$6.6M total, all under a 10b5-1 plan.
  • Director Christopher Patusky sold 1,200 shares open-market on Nov 9 for $702K, not under a 10b5-1 plan.
  • EVP & General Counsel Paul Mahon sold 526 shares open-market on Nov 5 for $312K, under a 10b5-1 plan.
  • Total open-market sales by the three insiders in the cluster window: ~$7.6M, representing approximately 0.03% of UTHR's $25.4B market cap.
  • Q3 2026 revenue of $832.5M beat the $781.1M consensus, but GAAP EPS of $5.71 missed the $6.04 consensus due to a $130M in-process R&D charge from the Thymmune acquisition.

Financial Impact

Total open-market insider sales of ~$7.6M, or 0.03% of market cap. CEO's sales alone were ~$6.6M.

insider ownership

Risk Factors

  • CEO's sales under a 10b5-1 plan reduce signaling value but still reduce her economic exposure.
  • Director Patusky's non-plan sale could indicate personal concern about valuation or business outlook.
  • Q3 EPS miss due to acquisition charges may weigh on near-term sentiment despite revenue beat.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1794605677050

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Viewing Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (9h 51m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026